Korro Bio, Inc. (KRRO) Executive Compensation
Korro Bio, Inc. (KRRO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KRRO
CIK: 1703647
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAaron Church
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001193125-26-414118 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | 4 Filing | 0001030575-26-000014 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001628280-26-061898 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001628280-26-061897 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-11 | 4 | 0001193125-26-390556 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001628280-26-061593 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001628280-26-061592 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001959173-26-006900 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | 4 | 0001193125-26-387852 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001959173-26-006837 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001959173-26-006800 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | 4 Filing | 0001030575-26-000012 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001628280-26-059122 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001628280-26-059121 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 Filing | 0001030575-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001628280-26-058030 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001628280-26-058029 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | 8-K | 0001193125-26-356877 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003427 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 Filing | 0001030575-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-06 | 4 Filing | 0000902664-26-003434 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001628280-26-055859 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001628280-26-055858 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336707 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-05 | 8-K | 0001193125-26-336685 | View SEC Doc Filr Page |